EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic and Prophylactic Agents for Viral Diseases: Current Status, Challenges, and Future Prospects

Sawar Khan, Ayesha Nisar, Xiaoxu Li, Hao Yu, Abdul Qadeer, Sardar Azhar Mehmood, Imane Lamraoui, Sijie Liu, Lipeng Zhu, Xu Deng, Bo Kong, Kejun Zhong und 1 weitere

MedComm · 2026-11 · 7 (11)

DOI: 10.1002/mco2.71024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 09.11.2026. Verfasst von Sawar Khan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Life Science Academy Beijing China. Die Arbeit nennt 510 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral diseases remain a major global health challenge despite substantial advances in vaccination, antiviral therapeutics, and public‐health interventions. However, current antiviral strategies are still constrained by important gaps, including rapid viral evolution, limited broad‐spectrum efficacy, immune escape, antiviral resistance, incomplete durability of protection, and inequitable global access to prevention and treatment. This review provides a comprehensive and integrated overview of contemporary antiviral prevention and therapeutic strategies, spanning vaccines, monoclonal antibodies, direct‐acting antivirals, host‐targeted therapies, immunomodulators, RNA‐based therapeutics, gene‐editing technologies, and cellular immunotherapies. We discuss the mechanistic foundations, clinical applications, pharmacologic considerations, and translational challenges associated with each modality across major human viral pathogens, including HIV, HBV, HCV, influenza, SARS‐CoV‐2, RSV, Ebola virus, arboviruses, and herpesviruses. Particular emphasis is placed on emerging innovations such as long‐acting prophylaxis, Fc‐engineered monoclonal antibodies, nanoparticle and mucosal vaccine platforms, CRISPR‐based antiviral systems, and broadly protective host‐directed approaches designed to overcome resistance and enhance pandemic preparedness. In addition, we highlight the growing importance of real‐time genomic surveillance and equitable global deployment strategies in shaping future antiviral responses, collectively underscoring that the next generation of antiviral medicine will depend on the convergence of universal immunization strategies, durable therapeutics, precision immune modulation, and rapidly deployable platform technologies capable of addressing both endemic and emerging viral threats.

Schlagwörter

Stichwörter der Autor:innen

CRISPRPrEP/PEPantiviralsbroad‐spectrum antiviralsmRNAvaccines

Autor:innen und Institutionen

  • Beijing Life Science Academy Beijing China.
  • Department of Cell Biology School of Life Sciences Central South University Changsha China.
  • Institute of Molecular Biology and Biotechnology The University of Lahore Lahore Pakistan.
  • State Key Laboratory of Genetic Evolution & Animal Models Key Laboratory of Healthy Aging Research of Yunnan Province Kunming Institute of Zoology Chinese Academy of Sciences Kunming Yunnan China.
  • Department of Zoology Hazara University Mansehra Pakistan.
  • Laboratory of Functional Ecology and Environment Faculty of Natural and Life Sciences Larbi Ben M'hidi University Oum El Bouaghi Algeria.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Khan, S., Nisar, A., Li, X., Yu, H., Qadeer, A., Mehmood, S. A., Lamraoui, I., Liu, S., Zhu, L., Deng, X., Kong, B., Zhong, K., & Xia, Z. (2026). Therapeutic and Prophylactic Agents for Viral Diseases: Current Status, Challenges, and Future Prospects. MedComm, 7(11). https://doi.org/10.1002/mco2.71024

Vancouver

Khan S, Nisar A, Li X, Yu H, Qadeer A, Mehmood SA, et al. Therapeutic and Prophylactic Agents for Viral Diseases: Current Status, Challenges, and Future Prospects. MedComm. 2026;7(11). doi:10.1002/mco2.71024

BibTeX
@article{Khan2026,
  author = {Khan, Sawar and Nisar, Ayesha and Li, Xiaoxu and Yu, Hao and Qadeer, Abdul and Mehmood, Sardar Azhar and Lamraoui, Imane and Liu, Sijie and Zhu, Lipeng and Deng, Xu and Kong, Bo and Zhong, Kejun and Xia, Zanxian},
  title = {Therapeutic and Prophylactic Agents for Viral Diseases: Current Status, Challenges, and Future Prospects},
  journal = {MedComm},
  year = {2026},
  volume = {7},
  number = {11},
  doi = {10.1002/mco2.71024}
}
Kostenlos starten →